The method and constituent for the medical treatment of diabetes and a related condition

Japanese Patent JP6089042

B2

The present invention is directed to methods and compositions for the treatment of diabetes and related symptoms. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diabetes and related symptoms. In a method aspect, the present invention provides a method of treating diabetes. The method involves ingesting 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diabetes.

Niihara, Yutaka

JP2014542296A

March 01, 2017

November 17, 2012

Click for automatic bibliography generation  

Emmaus Medical Incorporated

A61K31/198; A23L2/52; A23L33/175; A61K9/08; A61P3/10

WO2011038014A2
WO2010107307A1

田中 弘吉他,久留米医学会雑誌,1981年,Vol.44, No.9,10,p.654-661
Samocha-Bonet D, et al.,The Journal of Nutrition,2011年 7月,Vol.141,p.1233-1238
糖尿病用薬,治療薬マニュアル 2007,2007年,p.743-747
Tashima CM, et al.,Dig Dis Sci,2007年,Vol.52,p.1233-1241
Opara EC, et al.,The journal of nutrition,1996年,Vol.126, No.1,p.273-279
佐用義孝 他,2型糖尿病患者に対するDPP-4阻害薬シタグリプチンの投与6ヵ月間の臨床効果に関する検討,Therapeutic Research,2011年 4月,Vol.32, No.4,p523-529
内田大学 他,2型糖尿病におけるシタグリプチンの治療効果の検討,Progress in Medicine,2011年 3月,Vol.31,p911-916
柳澤守文 他,DPP-4阻害薬シタグリプチンの2型糖尿病に対する有用性の検討-血糖日動変動の影響についてSMBGを用いた検討-,医学と薬学,2010年,Vol.64, No.6,p887-894

Noboru Fujimoto
Hiroaki Nakatani
Shinji Nitto

Previous Patent: Pillar-shaped compound material structure and a manufacturing method which have a Covalent bond rein...

Next Patent: JPS6089043